Clinical practice. Fungal nail disease.
de Berker
David
D
Bristol Dermatology Centre, Bristol Royal Infirmary, University Hospitals Bristol, Bristol, United Kingdom. david.deberker@uhbristol.nhs.uk
D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D000077768:Ciclopirox; D003646:Debridement; D003937:Diagnosis, Differential; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use; D014009:Onychomycosis / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D017410:Practice Guidelines as Topic; D011728:Pyridones / Q000008:administration & dosage; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D011728:Pyridones; D000077768:Ciclopirox; D017964:Itraconazole; D000077291:Terbinafine